scholarly article | Q13442814 |
P2093 | author name string | Li Chen | |
Xudong Wu | |||
Xiaokun Li | |||
Huiping Zhou | |||
Shulin Yang | |||
Elaine Studer | |||
Phillip B Hylemon | |||
Guang Liang | |||
Faqing Ye | |||
Yueru Li | |||
Emily Gurley | |||
P2860 | cites work | Obesity, Inflammation, and Insulin Resistance | Q22250939 |
Anti-inflammatory drugs in the 21st century | Q28218028 | ||
Metabolic syndrome, inflammation and atherosclerosis | Q28219348 | ||
Effects of curcumin on retinal oxidative stress and inflammation in diabetes | Q28567589 | ||
Inflammatory mechanisms of diabetic complications | Q30443785 | ||
Therapeutic potential and strategies for inhibiting tumor necrosis factor-alpha | Q33680730 | ||
Immunomodulation by curcumin | Q33682687 | ||
Curcumin: the Indian solid gold | Q34004696 | ||
The role of chemokines and chemokine receptors in mucosal inflammation. | Q34125545 | ||
Multiple biological activities of curcumin: a short review | Q34564204 | ||
Antioxidant and anti-inflammatory properties of curcumin | Q34580325 | ||
Regulation of COX and LOX by curcumin | Q34580330 | ||
Turmeric--chemistry, technology, and quality | Q34714274 | ||
Multiple molecular targets in cancer chemoprevention by curcumin | Q36616301 | ||
Inflammation and disease progression | Q36653257 | ||
Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration | Q36694655 | ||
The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk | Q36698765 | ||
Inhibition of tumor necrosis factor by curcumin, a phytochemical | Q36708248 | ||
Pharmacokinetics and pharmacodynamics of curcumin | Q36849531 | ||
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. | Q40220230 | ||
Activation of NFkappaB is inhibited by curcumin and related enones | Q40341939 | ||
Curcumin is an in vivo inhibitor of angiogenesis | Q40884040 | ||
HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR. | Q44929692 | ||
Enhancement of wound healing by curcumin in animals | Q77426656 | ||
Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors | Q79486574 | ||
Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets | Q79712726 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | curcumin | Q312266 |
P304 | page(s) | 1525-1529 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
P1476 | title | Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin | |
P478 | volume | 18 |
Q41993585 | (1E,4E)-1,5-Bis(2,4-dimethyl-phen-yl)penta-1,4-dien-3-one |
Q28477019 | A novel compound C12 inhibits inflammatory cytokine production and protects from inflammatory injury in vivo |
Q36760651 | A novel fibroblast growth factor receptor 1 inhibitor protects against cartilage degradation in a murine model of osteoarthritis |
Q51031273 | A novel synthetic mono-carbonyl analogue of curcumin, A13, exhibits anti-inflammatory effects in vivo by inhibition of inflammatory mediators. |
Q44186295 | Acceleration of dermal wound healing by using electrospun curcumin-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) fibrous mats |
Q53773141 | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis. |
Q38732481 | An overview of structure-activity relationship studies of curcumin analogs as antioxidant and anti-inflammatory agents |
Q92026184 | Anti-Edematogenic and Anti-Granuloma Activity of a Synthetic Curcuminoid Analog, 5-(3,4-Dihydroxyphenyl)-3-hydroxy-1-(2-hydroxyphenyl)penta-2,4-dien-1-one, in Mouse Models of Inflammation |
Q38612383 | Antioxidant properties and PC12 cell protective effects of a novel curcumin analogue (2E,6E)-2,6-bis(3,5- dimethoxybenzylidene)cyclohexanone (MCH). |
Q90726396 | B14 ameliorates bone cancer pain through downregulating spinal interleukin-1β via suppressing neuron JAK2/STAT3 pathway |
Q39367047 | BDMC33, A curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: role of inhibition in NF-κB and MAPK signaling pathways |
Q34354189 | Biocomposite nanofibrous strategies for the controlled release of biomolecules for skin tissue regeneration |
Q40056019 | Curcumin analogue, A13, exhibits anti-leukemia effect via inhibiting STAT3. |
Q38072883 | Curcumin and liver disease. |
Q28488754 | Curcumin as a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase 1: improving lipid profiles in high-fat-diet-treated rats |
Q30433945 | Curcumin-loaded poly(epsilon-caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties |
Q38083084 | Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers |
Q37696946 | Discovery and evaluation of asymmetrical monocarbonyl analogs of curcumin as anti-inflammatory agents |
Q34482501 | Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin |
Q37109676 | EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells |
Q35034180 | Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs). |
Q35025704 | Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells |
Q35893304 | Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin |
Q36159004 | Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats |
Q46237295 | Novel allylated monocarbonyl analogs of curcumin induce mitotic arrest and apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and inhibition of STAT3. |
Q50451094 | PEG mediated synthesis and biological evaluation of asymmetrical pyrazole curcumin analogues as potential analgesic, anti-inflammatory and antioxidant agents |
Q87209237 | Potent anti-angiogenic activity of B19--a mono-carbonyl analogue of curcumin |
Q92466004 | Reinforcement of Polycaprolactone/Chitosan with Nanoclay and Controlled Release of Curcumin for Wound Dressing |
Q64057628 | Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study |
Q85965691 | Structure-Activity Relationships of the Antitumor C5-Curcuminoid GO-Y030 |
Q63245484 | Structures of Hemi-Curcuminoids in the Solid State and in Solution |
Q41332503 | Synthesis and Anti-Inflammatory Evaluation of Novel C66 Analogs for the Treatment of LPS-Induced Acute Lung Injury |
Q53727930 | Synthesis and Evaluation of Curcuminoid Analogues as Antioxidant and Antibacterial Agents. |
Q42863514 | Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophages |
Q38819526 | Synthesis of Novel β-Keto-Enol Derivatives Tethered Pyrazole, Pyridine and Furan as New Potential Antifungal and Anti-Breast Cancer Agents. |
Q38962810 | Synthesis, characterization and in vitro anticancer activity of C-5 curcumin analogues with potential to inhibit TNF-α-induced NF-κB activation. |
Q93361869 | Synthesis, crystal structure, DFT studies and biological activity of (Z)-3-(3-bromophenyl)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxyprop-2-en-1-one |
Q38823195 | W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. |